Literature DB >> 33742334

Identification of molecular biomarkers and pathways of NSCLC: insights from a systems biomedicine perspective.

Rakibul Islam1, Liton Ahmed1, Bikash Kumar Paul1,2,3, Kawsar Ahmed4,5, Touhid Bhuiyan1, Mohammad Ali Moni6.   

Abstract

BACKGROUND: Worldwide, more than 80% of identified lung cancer cases are associated to the non-small cell lung cancer (NSCLC). We used microarray gene expression dataset GSE10245 to identify key biomarkers and associated pathways in NSCLC.
RESULTS: To collect Differentially Expressed Genes (DEGs) from the dataset GSE10245, we applied the R statistical language. Functional analysis was completed using the Database for Annotation Visualization and Integrated Discovery (DAVID) online repository. The DifferentialNet database was used to construct Protein-protein interaction (PPI) network and visualized it with the Cytoscape software. Using the Molecular Complex Detection (MCODE) method, we identify clusters from the constructed PPI network. Finally, survival analysis was performed to acquire the overall survival (OS) values of the key genes. One thousand eighty two DEGs were unveiled after applying statistical criterion. Functional analysis showed that overexpressed DEGs were greatly involved with epidermis development and keratinocyte differentiation; the under-expressed DEGs were principally associated with the positive regulation of nitric oxide biosynthetic process and signal transduction. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway investigation explored that the overexpressed DEGs were highly involved with the cell cycle; the under-expressed DEGs were involved with cell adhesion molecules. The PPI network was constructed with 474 nodes and 2233 connections.
CONCLUSIONS: Using the connectivity method, 12 genes were considered as hub genes. Survival analysis showed worse OS value for SFN, DSP, and PHGDH. Outcomes indicate that Stratifin may play a crucial role in the development of NSCLC.

Entities:  

Keywords:  Gene expression; Gene ontology; KEGG pathway analysis; Molecular biomarkers; PPI network

Year:  2021        PMID: 33742334      PMCID: PMC7979844          DOI: 10.1186/s43141-021-00134-1

Source DB:  PubMed          Journal:  J Genet Eng Biotechnol        ISSN: 1687-157X


  38 in total

1.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

2.  Identification of NMU as a potential gene conferring alectinib resistance in non-small cell lung cancer based on bioinformatics analyses.

Authors:  Shuangjie You; Lei Gao
Journal:  Gene       Date:  2018-08-07       Impact factor: 3.688

Review 3.  The role of stratifin in fibroblast-keratinocyte interaction.

Authors:  Abelardo Medina; Abdi Ghaffari; Ruhangiz T Kilani; Aziz Ghahary
Journal:  Mol Cell Biochem       Date:  2007-07-24       Impact factor: 3.396

4.  Small adenocarcinoma of the lung. Histologic characteristics and prognosis.

Authors:  M Noguchi; A Morikawa; M Kawasaki; Y Matsuno; T Yamada; S Hirohashi; H Kondo; Y Shimosato
Journal:  Cancer       Date:  1995-06-15       Impact factor: 6.860

5.  NCBI GEO: archive for functional genomics data sets--update.

Authors:  Tanya Barrett; Stephen E Wilhite; Pierre Ledoux; Carlos Evangelista; Irene F Kim; Maxim Tomashevsky; Kimberly A Marshall; Katherine H Phillippy; Patti M Sherman; Michelle Holko; Andrey Yefanov; Hyeseung Lee; Naigong Zhang; Cynthia L Robertson; Nadezhda Serova; Sean Davis; Alexandra Soboleva
Journal:  Nucleic Acids Res       Date:  2012-11-27       Impact factor: 16.971

6.  Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer.

Authors:  Balázs Győrffy; Pawel Surowiak; Jan Budczies; András Lánczky
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

7.  Particular gene upregulation and p53 heterogeneous expression in TP53-mutated maxillary carcinoma.

Authors:  Itsuhiro Kudo; Mariko Esumi; Yoshiaki Kusumi; Tohru Furusaka; Takeshi Oshima
Journal:  Oncol Lett       Date:  2017-08-14       Impact factor: 2.967

8.  The family of 14-3-3 proteins and specifically 14-3-3σ are up-regulated during the development of renal pathologies.

Authors:  Myrto Rizou; Eleni A Frangou; Filio Marineli; Niki Prakoura; Jerome Zoidakis; Harikleia Gakiopoulou; George Liapis; Panagiotis Kavvadas; Christos Chatziantoniou; Manousos Makridakis; Antonia Vlahou; John Boletis; Demetrios Vlahakos; Dimitrios Goumenos; Evgenios Daphnis; Christos Iatrou; Aristidis S Charonis
Journal:  J Cell Mol Med       Date:  2018-06-28       Impact factor: 5.310

9.  Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective.

Authors:  Xiujuan Gao; Yue Cai; Zhuo Wang; Wenjuan He; Sisi Cao; Rong Xu; Hui Chen
Journal:  J Transl Med       Date:  2019-09-11       Impact factor: 5.531

10.  Stratifin accelerates progression of lung adenocarcinoma at an early stage.

Authors:  Aya Shiba-Ishii; Yunjung Kim; Toshihiro Shiozawa; Shinji Iyama; Kaishi Satomi; Junko Kano; Shingo Sakashita; Yukio Morishita; Masayuki Noguchi
Journal:  Mol Cancer       Date:  2015-07-30       Impact factor: 27.401

View more
  1 in total

1.  Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug-gene interaction networks analysis.

Authors:  Habib MotieGhader; Parinaz Tabrizi-Nezhadi; Mahshid Deldar Abad Paskeh; Behzad Baradaran; Ahad Mokhtarzadeh; Mehrdad Hashemi; Hossein Lanjanian; Seyed Mehdi Jazayeri; Masoud Maleki; Ehsan Khodadadi; Sajjad Nematzadeh; Farzad Kiani; Mazaher Maghsoudloo; Ali Masoudi-Nejad
Journal:  Sci Rep       Date:  2022-06-08       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.